Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome. A Prospective, Randomized, Double-blind, Placebo Controlled, Monocenter Study
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2015
Price : $35 *
At a glance
- Drugs Rufinamide (Primary) ; Oxycodone
- Indications Neuropathic pain; Postoperative pain
- Focus Therapeutic Use
- 20 Jul 2015 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 16 May 2014 New trial record
- 28 Apr 2014 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov.